11 Sep 2019
Taking ideas from bench to bedside is complicated. So, what’s the best way to progress exciting new ideas emerging in academia? Professor Simon Hollingsworth, Vice President and Global Medicine Leader at AstraZeneca, and Visiting Professor at Kings College London, chaired the advisory group of a report looking back over a decade of MRC translation funding. He shares what they found.
It’s well documented in the pharmaceutical sector that the path from discovery to clinical adoption and use of a new commercial product is long and perilous. It can take many years (sometimes more than 20 years) to bring a new product to market where it can benefit patients. [...]